BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Appolinario JC, Bueno JR, Coutinho W. Psychotropic Drugs in the Treatment of Obesity: What Promise? CNS Drugs 2004;18:629-51. [DOI: 10.2165/00023210-200418100-00002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Powell A, Aronne LJ, Apovian CM. Phentermine plus topiramate for the treatment of obesity. Expert Review of Endocrinology & Metabolism 2014;7:503-10. [DOI: 10.1586/eem.12.43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Billes SK, Greenway FL. Combination therapy with naltrexone and bupropion for obesity. Expert Opinion on Pharmacotherapy 2011;12:1813-26. [DOI: 10.1517/14656566.2011.591382] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
3 Boezio B, Audouze K, Ducrot P, Taboureau O. Network-based Approaches in Pharmacology. Mol Inform. 2017;36. [PMID: 28692140 DOI: 10.1002/minf.201700048] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 15.6] [Reference Citation Analysis]
4 Giel KE, Binkele M, Becker S, Stübler P, Zipfel S, Enck P. Weight reduction and maintenance in a specialized outpatient health care center. Obes Res Clin Pract 2008;2:I-II. [PMID: 24351771 DOI: 10.1016/j.orcp.2008.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Kral JG, Paez W, Wolfe BM. Vagal Nerve Function in Obesity: Therapeutic Implications. World J Surg 2009;33:1995-2006. [DOI: 10.1007/s00268-009-0138-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
6 Dyck B. Small molecule melanin-concentrating hormone receptor 1 (MCH1R) antagonists as anxiolytic and antidepressive agents. Drug Dev Res 2005;65:291-300. [DOI: 10.1002/ddr.20030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
7 Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts 2009;2:26-35. [PMID: 20054201 DOI: 10.1159/000194971] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
8 Billes SK, Sinnayah P, Cowley MA. Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Pharmacol Res 2014;84:1-11. [PMID: 24754973 DOI: 10.1016/j.phrs.2014.04.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis]
9 Janssen P, Van Oudenhove L, Casteels C, Vos R, Verbeke K, Tack J. The effects of acute citalopram dosing on gastric motor function and nutrient tolerance in healthy volunteers: Citalopram, gastric motor function and nutrient intake. Alimentary Pharmacology & Therapeutics 2011;33:395-402. [DOI: 10.1111/j.1365-2036.2010.04522.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
10 Bortolini LGC, Kulak CAM, Borba VZC, Silvado CE, Boguszewski CL. Efeitos endócrinos e metabólicos das drogas antiepilépticas. Arq Bras Endocrinol Metab 2009;53:795-803. [DOI: 10.1590/s0004-27302009000700002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Furlanetto LM, Brasil MA. Diagnosticando e tratando depressão no paciente com doença clínica. J bras psiquiatr 2006;55:8-19. [DOI: 10.1590/s0047-20852006000100002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Cooke D, Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 2006;5:919-31. [PMID: 17080028 DOI: 10.1038/nrd2136] [Cited by in Crossref: 147] [Cited by in F6Publishing: 121] [Article Influence: 9.2] [Reference Citation Analysis]
13 Tseng YH, Cypess AM, Kahn CR. Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 2010;9:465-82. [PMID: 20514071 DOI: 10.1038/nrd3138] [Cited by in Crossref: 386] [Cited by in F6Publishing: 352] [Article Influence: 32.2] [Reference Citation Analysis]
14 Lin S, Zhao X, Sun Y, Liu H, Shang M, Gong J, Ma Q, Piao G, Yuan H. Inhibitory effects of compounds from the roots of Potentilla longifolia on lipid accumulation. PLoS One 2020;15:e0238917. [PMID: 32903285 DOI: 10.1371/journal.pone.0238917] [Reference Citation Analysis]
15 Claudino AM, Silva de Lima M, Hay PP, Bacaltchuk J, Schmidt UU, Treasure J; Cochrane Common Mental Disorders Group. Antidepressants for anorexia nervosa. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd004365.pub2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
16 Palamara KL, Mogul HR, Peterson SJ, Frishman WH. Obesity: New Perspectives and Pharmacotherapies. Cardiology in Review 2006;14:238-58. [DOI: 10.1097/01.crd.0000233903.57946.fd] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
17 Cappon GD, Fleeman TL, Chapin RE, Hurtt ME. Effects of feed restriction during organogenesis on embryo-fetal development in rabbit. Birth Defects Res B Dev Reprod Toxicol 2005;74:424-30. [PMID: 16249998 DOI: 10.1002/bdrb.20058] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
18 Cooper SJ, Al-naser HA, Clifton PG. The anorectic effect of the selective dopamine D1-receptor agonist A-77636 determined by meal pattern analysis in free-feeding rats. European Journal of Pharmacology 2006;532:253-7. [DOI: 10.1016/j.ejphar.2005.11.046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
19 Uphouse L, Hensler JG, Sarkar J, Grossie B. Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats. Brain Res 2006;1072:79-90. [PMID: 16423328 DOI: 10.1016/j.brainres.2005.12.033] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
20 Fleeman T, Cappon G, Chapin R, Hurtt M. The effects of feed restriction during organogenesis on embryo-fetal development in the rat. Birth Defect Res B 2005;74:442-9. [DOI: 10.1002/bdrb.20056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
21 Nardi AE, Appolinário JC, da Silva AG. A tireless researcher in psychopharmacology and a gold-standard philosopher: the scientist and humanist João Romildo Bueno (1938-2019). Braz J Psychiatry 2019;41:378-9. [PMID: 31644778 DOI: 10.1590/1516-4446-2019-4111] [Reference Citation Analysis]
22 Billes SK, Cowley MA. Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis. Neuropsychopharmacology 2008;33:1287-97. [PMID: 17687262 DOI: 10.1038/sj.npp.1301526] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
23 Alén F, Orio L, Gorriti MÁ, de Heras RG, Ramírez-lópez MT, Pozo MÁ, de Fonseca FR. Increased alcohol consumption in rats after subchronic antidepressant treatment. International Journal of Neuropsychopharmacology 2013;16:1809-18. [DOI: 10.1017/s1461145713000217] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]